搜尋
Annexon Inc
ANNX添加自選
4.190USD
-0.020-0.48%
收盤 11-11 16:00（美東）
794.34M總市值
虧損本益比TTM
持股情況
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Redmile Group, LLC
6.13%
Alerce Investment Management, L.P.
5.94%
BVF Partners L.P.
5.57%
BlackRock Institutional Trust Company, N.A.
5.04%
Fidelity Management & Research Company LLC
4.07%
其他
73.25%
持股股東
持股股東
佔比
Redmile Group, LLC
6.13%
Alerce Investment Management, L.P.
5.94%
BVF Partners L.P.
5.57%
BlackRock Institutional Trust Company, N.A.
5.04%
Fidelity Management & Research Company LLC
4.07%
其他
73.25%
股東類型
持股股東
佔比
Investment Advisor
36.58%
Hedge Fund
27.02%
Investment Advisor/Hedge Fund
19.59%
Private Equity
5.96%
Research Firm
3.48%
Individual Investor
0.55%
Bank and Trust
0.37%
Endowment Fund
0.29%
Venture Capital
0.15%
其他
6.00%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
366
152.67M
93.19%
+19.08M
2025Q4
326
114.34M
87.99%
+2.37M
2025Q3
332
111.98M
117.07%
+1.75M
2025Q2
327
110.87M
120.59%
-2.74M
2025Q1
331
111.53M
128.12%
-29.03M
2024Q4
321
116.52M
125.08%
+3.18M
2024Q3
294
113.52M
124.58%
+3.02M
2024Q2
280
110.20M
112.90%
+10.89M
2024Q1
276
95.92M
114.20%
-7.41M
2023Q4
266
81.20M
93.20%
+27.04M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Redmile Group, LLC
10.05M
6.26%
+3.75M
+59.52%
Dec 31, 2025
Alerce Investment Management, L.P.
9.73M
6.06%
+2.32M
+31.36%
Nov 21, 2025
BVF Partners L.P.
9.13M
5.69%
+2.13M
+30.40%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
8.25M
5.14%
+1.15M
+16.25%
Dec 31, 2025
Fidelity Management & Research Company LLC
6.68M
4.16%
+1.58M
+30.96%
Dec 31, 2025
Adage Capital Management, L.P.
5.50M
3.43%
+4.00M
+266.67%
Dec 31, 2025
Bellevue Asset Management AG
5.16M
3.21%
--
--
Dec 31, 2025
State Street Investment Management (US)
4.65M
2.9%
+2.60M
+126.90%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
4.47M
2.79%
-774.94K
-14.76%
Dec 31, 2025
查看更多
ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
0.79%
iShares Neuroscience and Healthcare ETF
0.72%
ALPS Medical Breakthroughs ETF
0.13%
ProShares Ultra Nasdaq Biotechnology
0.06%
iShares Micro-Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Value ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.03%
iShares Biotechnology ETF
0.03%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.79%
iShares Neuroscience and Healthcare ETF
佔比0.72%
ALPS Medical Breakthroughs ETF
佔比0.13%
ProShares Ultra Nasdaq Biotechnology
佔比0.06%
iShares Micro-Cap ETF
佔比0.06%
Avantis US Small Cap Equity ETF
佔比0.04%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.03%
iShares Russell 2000 Value ETF
佔比0.03%
Invesco Nasdaq Biotechnology ETF
佔比0.03%
iShares Biotechnology ETF
佔比0.03%